Furthermore, recent studies suggested that HIF1a protein can increase Gal-1 expression in colon cancer by binding to DNA to promote transcription of the Gal-1 gene, whereas shRNA-mediated silencing of HIF1a expression antagonized hypoxia-induced Gal-1 expression [24]. Here, HIF1A is linked to malignant colon neoplasm.